Hereditary hemochromatosis. Phenotypic expression of the disease.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  New England Journal of Medicine

• Publication date

  1979-07-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1056/NEJM197907263010402PMID 449974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Organelle Pathology in Primary and Secondary Haemochromatosis with Special Reference to Lysosomal Changes

  1978cited by this paper
• B‐Lymphocyte Alloantigens

  1977cited by this paper
• Heredity of idiopathic haemochromatosis: A study of 106 families

  1977cited by this paper
• Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing.

  1977cited by this paper
• B-lumphocyte alloantigens.

  1977cited by this paper
• Hereditary hemochromatosis. Diagnosis in siblings and children.

  1977cited by this paper
• Iron storage disorders of the liver.

  1974cited by this paper
• Hepatic cirrhosis: A clinico-pathological review of 520 cases

  1973cited by this paper
• Prevention of Wilson's disease in asymptomatic patients.

  1968cited by this paper
• IDIOPATHIC HEMOCHROMATOSIS, AN IRON STORAGE DISEASE: A. Iron Metabolism in Hemochromatosis

  1955cited by this paper

• Liver iron concentration thresholds: Where do they really come from?

  2025influential citation
• Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRI.

  2022cites this paper
• A deep learning approach to identify association of disease–gene using information of disease symptoms and protein sequences

  2020cites this paper
• Physical and Physiological Properties of Iron

  2020cites this paper
• Iron Mapping Techniques and Applications

  2020cites this paper
• Hereditary hemochromatosis is associated with increased use of joint replacement surgery: Results of a nationwide analysis.

  2019cites this paper
• Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post‐hematopoietic stem cell transplantation

  2018cites this paper
• Effect of pH on the stability of hemochromatosis factor E: a combined spectroscopic and molecular dynamics simulation-based study

  2017cites this paper
• Increased Incidence in Homozygous Men

  2016cites this paper
• Erkrankungen der Gelenke

  2016cites this paper
• Hemochromatosis: Niche Construction and the Genetic Domino Effect in the European Neolithic

  2015influential citation
• Hepatic Iron in African Americans Who Underwent Liver Biopsy

  2014cites this paper
• Transfusional iron overload and iron chelation therapy in thalassemia major and sickle cell disease.

  2014cites this paper
• Total and Cause-Specific Mortality by Elevated Transferrin Saturation and Hemochromatosis Genotype in Individuals With Diabetes: Two General Population Studies

  2014cites this paper
• Non-Hfe Iron Overload: Is Phlebotomy the Answer?

  2013cites this paper
• Iron Metabolism and Related Disorders

  2013cites this paper
• Total Mortality by Elevated Transferrin Saturation in Patients With Diabetes

  2013cites this paper
• Current management of sickle cell anemia.

  2013cites this paper
• Hemochromatosis and iron overload: from bench to clinic.

  2013cites this paper
• Management of the thalassemias.

  2013cites this paper
• changes in iron metabolism induced by doxorubicin Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates

  2013cites this paper
• Overview of current chelation practices

  2012cites this paper
• Clinical Use of Iron Chelators

  2012cites this paper
• Alternative Polyadenylation and Nonsense-Mediated Decay Coordinately Regulate the Human HFE mRNA Levels

  2012cites this paper
• Differential HFE Gene Expression Is Regulated by Alternative Splicing in Human Tissues

  2011cites this paper
• Total mortality by transferrin saturation levels: two general population studies and a metaanalysis.

  2011cites this paper
• Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease.

  2011cites this paper
• Pathogenesis and Management of Iron Overload in MDS

  2011influential citation
• Elevated Transferrin Saturation and Risk of Diabetes

  2011cites this paper
• Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapies.

  2010cites this paper
• Why concentration of serum ferritin does not in all circumstances reflect storage iron but is still of value in its estimation.

  2009cites this paper
• Regional differences in the idiopathic hemochromatosis gene frequency in Sweden.

  2009cites this paper
• Prevalence of hemochromatosis in Finland.

  2009cites this paper
• Disorders of Hemoglobin: THE β THALASSEMIAS

  2009cites this paper
• Prevalence of iron overload in central Sweden.

  2009cites this paper
• Screening for iron overload using transferrin saturation.

  2009cites this paper
• Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer.

  2008cites this paper
• α-Fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer

  2008cites this paper
• [Diagnostic procedure in hemochromatosis].

  2008cites this paper
• Iron-Mediated Inhibition of Mitochondrial Manganese Uptake Mediates Mitochondrial Dysfunction in a Mouse Model of Hemochromatosis

  2008cites this paper
• Interactions in Metal Toxicology

  2007cites this paper
• Hemosiderosis and diabetes mellitus in an untransfused patient with hemoglobin H disease and H63D homozygous hereditary hemochromatosis.

  2007cites this paper
• Screening for hemochromatosis?

  2007cites this paper
• The Cytoplasmic Domain of Transferrin Receptor 2 Dictates Its Stability and Response to Holo-transferrin in Hep3B Cells*

  2007cites this paper
• Serum Ferritin in Stroke: A Marker of Increased Body Iron Stores or Stroke Severity?

  2005cites this paper
• Antagonistic pleiotropy, mutation accumulation, and human genetic disease

  2005cites this paper
• Idiopathic hemochromatosis: demonstration of homozygous-heterozygous mating by HLA typing of families

  2004influential citation
• The frequency of C282Y and H63D mutations in Hemochromatosis gene in native Estonians

  2004cites this paper
• The role of HFE mutations on iron metabolism in beta-thalassemia carriers

  2004cites this paper
• HLA as a marker of the hemochromatosis gene in Sweden

  2004cites this paper
• Frequencies of the Hereditary Hemochromatosis Allele in Different Populations. Comparison of Previous Phenotypic Methods and Novel Genotypic Methods

  2003influential citation
• The Impact of Test Outcome Certainty on Interest in Genetic Testing Among College Women

  2003cites this paper
• Potential role of increased iron stores in diabetes.

  2003cites this paper
• Does the gerbil model mimic human iron overload?

  2003cites this paper
• Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin.

  2003cites this paper
• Prevalence of Hemochromatosis Gene (HFE) Mutations in Greece

  2003cites this paper
• Orally active iron chelators.

  2002cites this paper
• From Zebrafish to human: modular medical models.

  2002cites this paper
• Iron does not bind to the Apo‐B protein of low‐density lipoprotein

  2002cites this paper
• HFE based re-evaluation of heterozygous hemochromatosis.

  2002cites this paper
• Genetic heterogeneity underlies juvenile hemochromatosis phenotype: analysis of three families of northern Greek origin.

  2002cites this paper
• Liver disease in transfusion dependent thalassaemia major

  2002cites this paper
• Earliest cardiac toxicity induced by iron overload selectively inhibits electrical conduction.

  2002cites this paper
• Hereditary hemochromatosis.

  2002cites this paper
• Survey of physician knowledge about hemochromatosis

  2002cites this paper
• Survey of physician knowledge about

  2002cites this paper
• Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis

  2002cites this paper
• T-cell receptor repertoire in hereditary hemochromatosis: a study of 32 hemochromatosis patients and 274 healthy subjects.

  2001cites this paper
• Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease.

  2001cites this paper
• Lebergentherapie: Aktueller Stand und Ausblick

  2001cites this paper
• Comparative study of the two more frequent HFE mutations (C282Y and H63D): significant different allelic frequencies between the North and South of Portugal

  2001cites this paper
• Secondary iron overload.

  2001cites this paper
• Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload

  2001cites this paper
• Progression of iron overload in sickle cell disease.

  2001cites this paper
• Linkage to chromosome 1q in Greek families with juvenile hemochromatosis.

  2001cites this paper
• A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study.

  2001cites this paper
• Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study.

  2001cites this paper
• HFE mutations do not account for transfusional iron overload in patients with acute myeloid leukemia

  2001cites this paper
• Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity.

  2000cites this paper
• Disorders of Mineral Metabolism

  2000cites this paper
• Stoffwechselerkrankungen der Leber

  2000cites this paper
• Cell surface expression of HFE protein in epithelial cells, macrophages, and monocytes.

  2000cites this paper
• Biochemical expression of heterozygous hereditary hemochromatosis.

  2000cites this paper
• Non‐transferrin‐bound iron is present in serum of hereditary haemochromatosis heterozygotes

  2000cites this paper
• Hereditary hemochromatosis: should clinicians screen for this common disease?

  2000cites this paper
• Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.

  2000cites this paper
• Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase

  2000cites this paper
• Iron overload and iron-chelating therapy in hemoglobin E-beta thalassemia.

  2000cites this paper
• Transfusionsbedingte Lebersiderose bei Patienten mit hämatologischen Neoplasien nach hämatopoetischer Stammzelltransplantation

  2000cites this paper
• An investigation into variability in the therapeutic response to deferiprone in patients with thalassemia major.

  1999cites this paper
• Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum.

  1999cites this paper
• The β-Thalassemias

  1999cites this paper
• The beta-thalassemias.

  1999cites this paper
• Syncope and Inducible Ventricular Fibrillation in a Woman with Hemochromatosis

  1999cites this paper
• Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation

  1999cites this paper
• Interrelationships of alcohol and iron in liver disease with particular reference to the iron‐binding proteins, ferritin and transferrin

  1999cites this paper
• Molecular medicine and hemochromatosis: at the crossroads.

  1999cites this paper
• Zyto- und Histotechnologie in der hämatopathologischen Diagnostik

  1999cites this paper
• Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1.

  1999cites this paper
• No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation

  1999cites this paper